Chugai Pharmaceutical revenue and financials
¥6,101.00Change from previous close: −0.31%Absolute change: −¥19.00
In the fiscal year ended December 2025, Chugai Pharmaceutical reported revenue of ¥1.26T (+7.46% year over year). Net income was ¥434.01B, a net margin of 34.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +7.46%
- 2025 vs 2024
- Net income growth
- +12.06%
- 2025 vs 2024
- Net margin
- 34.5%
- 2024: 33.1%
Financial data
Amounts in millions of JPY; per-share values in JPY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 2,468,595 | 2,208,373 | 1,932,547 | 1,869,758 | — |
| Current assets | 1,740,758 | 1,606,043 | 1,366,426 | 1,336,537 | — |
| Cash and equivalents | 426,602 | 540,202 | 458,674 | 222,169 | — |
| Short-term investments | 553,094 | 456,143 | 280,308 | 280,938 | — |
| Inventory | 276,848 | 240,067 | 273,480 | 292,206 | — |
| Net property, plant and equipment | 479,481 | 441,554 | 420,701 | 386,651 | — |
| Other intangible assets | 54,539 | 17,868 | 19,860 | 25,141 | — |
| Current liabilities | 411,077 | 290,357 | 288,217 | 423,730 | — |
| Accounts payable | 127,247 | 65,353 | 112,468 | 209,835 | — |
| Total liabilities | 442,863 | 306,874 | 306,967 | 445,371 | — |
| Total equity (incl. minority) | 2,025,732 | 1,901,499 | 1,625,580 | 1,424,387 | — |